FDA Inspection 1168012 — Pharmathen International S.A.
The FDA completed an inspection of Pharmathen International S.A. on December 9, 2021 in Rodopi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 9, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Rodopi (Greece)
Additional Details
Mutual Recognition Agreement (MRA)